13 April 2021 | Online: BST (UTC+1)
The programme brings together world leaders from international pharmaceutical organisations and leading biotechnology companies as well as globally active regulatory agencies to discuss the latest in organoid discovery.
Access the conference brochure for presentation details, topic areas and confirmed speakers for our Organoid Discovery Symposium.
Full Registration is now open for Organoid Discovery Symposium. Please click the button below to register for this event.
Our LinkedIn group aims to foster discussion and collaboration between experts interested in the latest tools and strategies for organoid discovery.
Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions working within organoid discovery
The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future
Below were some of the speakers of 2020’s Discovery Series: Virtual
Karolinska Institute and SciLifeLab
Skaggs School Of Pharmacy And Pharmaceutical Sciences, University Of Colorado Anschutz Medical Campus
NMI Natural and Medical Sciences Institute at the University of Tübingen
F. Hoffmann-La Roche Innovation Center Basel
Karlsruhe Institute of Technology
Hubrecht Organoid Technology
Networking and knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual, remote experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development services company providing translational platforms to advance oncology, immunology, inflammation, and metabolic disease research. Our biomarker discovery, validation, and assay services help our clients to successfully advance their preclinical and clinical therapeutic candidates.
HUB was founded by the Hubrecht Institute, the University Medical Center Utrecht, and the Royal Netherlands Academy of Arts and Sciences (KNAW). HUB’s technology constitutes a paradigm-shifting platform for drug discovery and development, (pre)clinical patient stratification, predictive diagnostics, personalized medicine, clinical trials, regenerative medicine, and companion diagnostics.
HUB exploits the pioneering work of Prof. Dr. Hans Clevers, who discovered the HUB Organoid Technology methods how to grow ‘mini-organs’ – organoids – from epithelial tissue derived adult stem cells.
HUB is the global leader in Organoid Technology with over 150 patents and many more patent applications that provide broad coverage for its Organoid Technology across twenty different jurisdictions worldwide. HUB offers licenses to its proprietary Organoid Technology and provides (pre)clinical and clinical trial services, research and development collaborations, predictive diagnostics, and access to its ‘living organoid biobanks’.
With over 30 years’ experience, we are one of the world’s leading providers of high-content imaging (HCI) and high-content screening (HCS) solutions, ranging from basic automated digital microscopy to advanced high-throughput confocal imaging for phenotypic screening of complex 3D models and organoids.
Our recently launched ImageXpress Confocal HT.ai High-Content Imaging System utilizes a seven-channel laser light source with eight imaging channels to enable highly multiplexed assays while maintaining high–throughput by using shortened exposure times. Water immersion objectives improve image resolution and minimize aberrations, so scientists can see deeper into thick samples.
For a fully end-to-end solution, our imaging systems are also supported by powerful high-content image acquisition and analysis software. MetaXpress and IN Carta™ software simplifies workflows for advanced phenotypic classification and 3D image analysis with machine learning capabilities and an intuitive user interface. Organoids can be characterized for diameter, volume, shape, intensity of specific marker, or distance to other objects.
